Who owns Pavmed?

Tip: Access positions for across all investors

Analyze quarterly positions in Pavmed with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Pavmed stock

Who bought or sold Pavmed this quarter?

There are no current stakeholders of Pavmed.

This is normal when the security:

  • Has been acquired or taken private
  • Has merged with another entity
  • Has changed its name and has a new CUSIP (and/or symbol)
  • Has been delisted and the ticker has changed

Please use Search to find the security you were looking for.

Who sold out of Pavmed?

Fund or Company Name Date Sold Shares Held Valued At
Vanguard Group Sep 2023 3.8M $1.1M
Wells Fargo & Company Sep 2023 302k $89k
Levin Capital Strategies Sep 2023 150k $44k
Lido Advisors Sep 2023 120k $35k
First Wilshire Securities Management Sep 2023 100k $29k
Lazari Capital Management Sep 2023 89k $26k
Charles Schwab Investment Management Sep 2023 80k $23k
Buckingham Asset Management Sep 2023 70k $21k
King Wealth Management Sep 2023 55k $16k
Two Sigma Securities Sep 2023 53k $16k
Tradition Wealth Management Sep 2023 53k $16k
Putnam Fl Investment Management Sep 2023 52k $15k
Citadel Advisors Sep 2023 45k $13k
Jane Street Sep 2023 39k $11k
Glassman Wealth Services Sep 2023 35k $10k
Millennium Management Sep 2023 33k $9.7k
Feltz Wealth PLAN Sep 2023 32k $9.5k
Wolverine Trading Sep 2023 15k $4.4k
Creative Planning Sep 2023 11k $3.3k
Victory Capital Management Sep 2023 11k $3.2k
Modera Wealth Management Sep 2023 11k $3.2k
Advisor Group Holdings Sep 2023 4.4k $1.3k
UBS Group Sep 2023 1.2k $354.000000
M&r Capital Management Sep 2023 1.0k $295.000000
Royal Bank of Canada Sep 2023 730.00 $0
Us Bancorp Sep 2023 500.00 $147.000000
Jpmorgan Chase & Co Sep 2023 347.00 $102.712000
Wolverine Asset Management Sep 2023 110.00 $31.999000
Bank of America Corporation Sep 2023 100.00 $29.000000